Attached files
| file | filename |
|---|---|
| 10-Q - GENEREX BIOTECHNOLOGY CORP | v205023_10q.htm |
| EX-31.1 - GENEREX BIOTECHNOLOGY CORP | v205023_ex31-1.htm |
| EX-31.2 - GENEREX BIOTECHNOLOGY CORP | v205023_ex31-2.htm |
Exhibit
32
CERTIFICATIONS
Pursuant
to Section 906 of the Public Company Accounting Reform and Investor Protection
Act of 2002 (18 U.S.C. ss. 1350, as adopted), Mark A. Fletcher, Interim Chief
Executive Officer and President of Generex Biotechnology Corporation (the
"Company"), and Rose C. Perri, Chief Financial Officer of the Company, each
hereby certifies that, to the best of their knowledge:
1. The
Company's Quarterly Report on Form 10-Q for the period ended October 31, 2010 to
which this Certification is attached as Exhibit 32 (the "Report") fully complies
with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934, as amended; and
2. The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company at the end of
the period covered by the Report.
|
DATE:
December 10, 2010
|
By: /s/ Mark A. Fletcher
|
|
Mark
A. Fletcher
|
|
|
Interim
President & Chief Executive Officer
|
|
|
(Principal
Executive Officer)
|
|
|
DATE:
December 10, 2010
|
By: /s/ Rose C. Perri
|
|
Rose
C. Perri
|
|
|
Chief
Financial Officer
|
|
|
(Principal
Financial and Accounting
Officer)
|